Fig. 1 · Structure
Documents & Downloads
HDAC-IN-55
Anticancer Agent
HDAC-IN-55 is a small molecule inhibitor targeting histone deacetylases (HDACs), yielding potential anticancer effects. This compound has been shown to enhance the expression of E-cadherin while inhibiting the proliferation of various cancer cell lines. Its activity suggests applications in cancer research, particularly in studies focusing on epithelial-to-mesenchymal transition and tumor suppressive mechanisms.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1268674-16-3 |
| Applications | Anticancer Agent |
| Formula | C17H17N3O3 |
| Molecular Weight | 311.34 |
| SMILES | O=C(C1=NOC(C2=CC=CO2)=C1)NCCCCC3=CC=NC=C3 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.